ALKBH5 modulates m6A modification to enhance acute myeloid leukemia resistance to adriamycin. Biomol Biomed [Internet]. 2025 Apr. 3 [cited 2025 Apr. 19];25(5):1038–1051. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/11076